Fundraising FoxLevation Pharma
1 known investors
Find your way into Levation Pharma
Sign up to see every warm intro you have to Levation Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Levation Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Levation Pharma is a pharmaceutical company developing LEV-102, a topical oxymetazoline-based gel for treating acquired blepharoptosis (drooping upper eyelids). The product is in a Phase I/II clinical trial in the U.S. and is not yet approved for sale.
Investors · 1
In the news
Frequently asked questions
- What does Levation Pharma do?
- Levation Pharma is a pharmaceutical company developing LEV-102, a topical oxymetazoline-based gel for treating acquired blepharoptosis (drooping upper eyelids). The product is in a Phase I/II clinical trial in the U.S. and is not yet approved for sale.
- Who are Levation Pharma's investors?
- Levation Pharma's investors include Peregrine Ventures.